|
| 金域医学(603882)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2023-10-10 | 146.75 | 0.31% | 46418.01 | 312.37 | 46418.01 | 99.33% | 股权激励期权行权 | | 2023-02-17 | 16.50 | 0.04% | 46418.01 | 312.37 | 46418.01 | 99.33% | 股权激励期权行权 | | 2022-09-23 | 134.75 | 0.29% | 46401.51 | 312.37 | 46401.51 | 99.33% | 股权激励期权行权 | | 2022-03-02 | 20.50 | 0.04% | 46266.76 | 312.37 | 46266.76 | 99.33% | 股权激励期权行权 | | 2021-12-06 | 162.75 | 0.35% | 46246.26 | 312.37 | 46246.26 | 99.33% | 股权激励期权行权 | | 2020-09-09 | 17824.52 | 38.93% | 45788.46 | 0.00 | 45788.46 | 100.00% | 发行前股份限售流通 | | 2018-09-10 | 21095.94 | 46.07% | 27963.94 | 17824.52 | 45788.46 | 100.00% | 发行前股份限售流通 |
|